Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trialTao Jiang, Shengxiang Ren, Jie Zhang et al.|Signal Transduction and Targeted Therapy|2021Cited by 94
Biological effects of BMP7 on small-cell lung cancer cells and its bone metastasisWeiwei Shen, Helong Zhang|International Journal of Oncology|2018Cited by 20